The bank of biological material in the SU.VI.MAX study;La biothèque dans l'étude SU.VI.MAX

Revue d'Epidemiologie et de Sante Publique

Volumn 51, Issue 1 II, 2003, Pages 147-150

  Galan, P ^a   Favier, A ^b   Preziosi, P ^a   Bertrais, S ^a   Arnault, N ^a   Hercberg, S ^a  

^a INSERM   (France)

^b GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

Bank of biological material; Cohort

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; MINERAL; PLACEBO; RETINOL; SELENIUM; VITAMIN; ZINC;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; BANK OF BIOLOGICAL MATERIALS; BIOLOGICAL BANK; CANCER; CANCER PREVENTION; CARDIOVASCULAR DISEASE; CLINICAL PROTOCOL; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; FEMALE; HEALTH CARE FACILITY; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PLASMA; RANDOMIZED CONTROLLED TRIAL; VITAMIN INTAKE; BLOOD; BLOOD BANK; BLOOD STORAGE; CRYOPRESERVATION; FRANCE; LABORATORY DIAGNOSIS; METHODOLOGY; MIDDLE AGED; NEOPLASM; ORGANIZATION AND MANAGEMENT;

ADULT; ANTIOXIDANTS; BLOOD BANKS; BLOOD PRESERVATION; CARDIOVASCULAR DISEASES; COHORT STUDIES; CRYOPRESERVATION; DIETARY SUPPLEMENTS; FEMALE; FRANCE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; RANDOMIZED CONTROLLED TRIALS; SPECIMEN HANDLING;

EID: 0037647179     PISSN: 03987620     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (2)

1. Hercberg S, Galan P, Preziosi P, Roussel AM, Arnaud J, Richard MJ, et al. Background and rationale behind the SU.VI.MAX study, a prevention trial using nutritional doses of a combination of antioxidant vitamins and minerals to reduce cardiovascular diseases and cancers. Int J Vit Nutr Res 1997; 68: 3-20.
2. Hercberg S, Preziosi P, Briançon S, Galan P, Paul-Dauphin A, Malvy D, et al. A primary prevention trial of nutritional doses of antioxidant vitamins and minerals on cardiovascular diseases and cancers in general population: the SU.VI.MAX Study. Design, methods and participants characteristics. Control Clin Trials 1997; 19: 336-51.